Literature DB >> 10564192

Hyperthermia enhances cytomegalovirus regulation of HIV-1 and TNF-alpha gene expression.

G K Iwamoto1, A M Ainsworth, P L Moseley.   

Abstract

The immediate-early (IE) genes of human cytomegalovirus (CMV) can be expressed in monocytic cells and are known to regulate viral and cellular genes. Reactivation of human immunodeficiency virus (HIV-1) may be stimulated by a variety of factors including other viruses and inflammatory cytokines. These studies examine the role of hyperthermia and CMV in the regulation of HIV-1 and tumor necrosis factor (TNF)-alpha. THP-1 cells were transfected with the CMV IE genes. HIV-1 and TNF-alpha transcription were assessed with chloramphenicol acetyltransferase promoter constructs. Hyperthermia sufficient to stimulate production of heat shock proteins was used to stimulate the cells. Hyperthermia significantly enhances the effect of CMV IE gene products on the expression of HIV-1 and TNF-alpha. The increases in HIV-1 transcription appear to be in part due to increases in TNF-alpha. Heat shock proteins induced by hyperthermia may play an important role in the viral regulation of monocytic function by CMV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564192     DOI: 10.1152/ajplung.1999.277.5.L1051

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Increased susceptibility of glutamine-depleted monocytes to fever-range hyperthermia: the role of 70-kDa heat shock protein.

Authors:  Jürgen Pollheimer; Maria Zellner; Maja Munk Eliasen; Erich Roth; Rudolf Oehler
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

2.  Heat shock enhances CMV-IE promoter-driven metabotropic glutamate receptor expression and toxicity in transfected cells.

Authors:  Sergey Pshenichkin; Alexander Surin; Elena Surina; Małgorzata Klauzińska; Ewa Grajkowska; Victoria Luchenko; Monika Dolińska; Barbara Wroblewska; Jarda T Wroblewski
Journal:  Neuropharmacology       Date:  2011-01-15       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.